Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?

This publication has 21 references indexed in Scilit:

• Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride
  Endocrinology, 1995
• Benign Prostatic Hyperplasia — Medical and Minimally Invasive Treatment Options
  New England Journal of Medicine, 1995
• Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor
  Urology, 1994
• Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia
  Urology, 1994
• Finasteride
  New England Journal of Medicine, 1994
• The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1992
• Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.
  Proceedings of the National Academy of Sciences, 1991
• The clinical development of a 5α-reductase inhibitor, finasteride
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• 5α-Reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat
  Steroids, 1986
• Prostatic effects induced in dogs by chronic or acute oral administration of 5α‐reductase inhibitors
  The Prostate, 1986